open collaboration

WELL Health Technologies Corp....is pleased to announce it has entered into a Memorandum of Understanding (the "MOU") with McMaster University's Department of Family Medicine that authorizes WELL to use the OSCAR brand...OSCAR, an acronym for "Open Source Clinical Application Resource", is an open-source EMR or Electronic Medical Records system created by McMaster and the open-source community to enable better care, connect clinicians and data for continuous learning, and deliver improved outcomes for patients and the health system. By using the OSCAR brand, WELL affirms its commitment to the core brand principles of open collaboration, clinician-driven innovation and ethical data practices. The MOU outlines a Strategic Alliance between WELL and McMaster for Technology Enabled Positive Health and Social Impact. Through this strategic alliance, WELL and McMaster will collaborate on initiatives that leverage OSCAR in ways that strengthen their shared commitment to ethical, innovative leadership in health and society. Read More »

...Healthcare NExT, a new initiative to dramatically transform health care, will deeply integrate greenfield research and health technology product development, as well as establish a new model at Microsoft for strategic health industry partnerships. Through these collaborations between health care partners and Microsoft’s AI and Research organization, our goal is to enable a new wave of innovation and impact using Microsoft’s deep AI expertise and global-scale cloud.This initiative includes investments in resources for our partners to capture new opportunities to apply AI to healthcare, such as the Microsoft AI in Health Partner Alliance, an expanding group of partners focused on advancing health technology. Alliance members will receive unique training and access to Microsoft technologies, engineering expertise and data sets. Read More »

OSI to contribute to Digital Public Goods Alliance’s mission to address world’s most pressing economic challenges by furthering adoption of Open Source software...The DPGA is part of the response to the United Nation’s call to end poverty, protect the planet and improve the lives and prospects of everyone, everywhere.  The announcement was made as part of the opening keynote at the Free and Open Source Developers Meeting (FOSDEM) and celebration of OSI’s 25 year anniversary.The DPGA is a multi-stakeholder initiative with a mission to accelerate the attainment of the Sustainable Development Goals (SDGs) in low- and middle-income countries by facilitating the discovery, development, use of and investment in digital public goods. Digital public goods are Open Source software, open data, open AI models, open standards and open content that adhere to privacy and other applicable laws and best practices, do no harm by design and help attain SDGs.

Read More »

This year's three-day OSEHRA Open Source Summit promises to be the most diverse ever, highlighting open source initiatives across a dozen Federal and State agencies, and showcasing industry progress in key areas such as emerging hybrid proprietary/open source interoperability solutions and synthetic patient data generation...This year's agenda includes a combination of engaging track sessions, town-hall discussion, and plenary events. The content will be exceptionally diverse, including: An interoperability platform demonstration drawing healthcare data from multiple health record systems; A demonstration of synthetic patient data generation, including the first public demonstration of tailored synthetic data being loaded into the open source VistA Electronic Health Record (EHR) via a new open source data loader...

Read More »

The Parker Foundation today announced a $250 million grant to launch the Parker Institute for Cancer Immunotherapy, a collaboration between many of the country's best scientists, clinicians and industry partners to lead an unprecedented cancer immunotherapy research effort. The gift is the largest single contribution ever made to the field of immunotherapy. The Parker Institute's goal is to accelerate the development of breakthrough immune therapies capable of turning cancer into a curable disease by ensuring the coordination and collaboration of the field's top researchers and quickly translating their findings into patient treatments.

Read More »